Ford Just Launched Billion: Is F Stock a Buy Today?
Ford just revealed a bold $2 billion energy push designed to power AI data centers. This article breaks down what the...
Why Index Funds Offer More Control Than Target Date
Index funds generally provide more control over allocations than target date funds, which automate drift. This intro explains what that means in practice.
28,480 articlesVernova First Months 2026: Momentum, Risks, and Outlook
GE Vernova surprised investors with strong momentum in the first half of 2026. This article breaks down what powered ...
Pale Fire Capital Bets Big on Healthcare with Baxter Stock Move
A boutique investor firm makes a bold healthcare bet by accumulating over 2 million Baxter International shares. The ...
Forget Vistra: One Quarter of Orders Surpasses Last Year
GE Vernova reports $18.3 billion in Q1 2026 orders and a $150 billion backlog, underscoring a durable AI-driven capex...
What Know About Million-Dollar Bet on Monday.com Amid 75% Drop
A major fund disclosed a $38 million stake in monday.com as the stock collapsed by about 75%. This article explains w...
Kontoor Brands Stock Popped: Why It Jumped Today
Kontoor Brands stock popped as the company posted a better-than-expected quarter and issued a brighter path for 2026....
Robinhood Stock Plunged February: What Investors Should Know
February brought a sharp pullback for Robinhood, driven by crypto swings and a broader shift in its business model. T...
Klarna (Klar) 2025 Earnings: Key Insights for Investors
If Klarna reveals its 2025 earnings trajectory, investors will look at growth, profitability, and risk factors more t...
Pool Corp (POOL) 2025 Outlook From Q4 Earnings Insights
As Pool Corp closes its Q4, investors weigh the implications for pool corp (pool) 2025. This guide breaks down the ea...
Ituran (ITRN) 2025 Earnings: A Roadmap for Investors
As Ituran gears up for its 2025 earnings, investors want clarity on growth, margins, and cash flow. This guide breaks...
Jazz Pharmaceuticals' Lung Cancer Setback: Stock Impact
A late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
JPMorgan’s Race Heats Case for a Two-Person Succession
JPMorgan Chase moves to a two-person succession test by naming Doug Petno and Troy Rohrbaugh co-presidents, laying th...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status